Mortality Risk Factors Among Critically Ill Children With Acute COVID-19 in PICUs : A Multicenter Study From Turkish Pediatric Critical COVID-19 and MIS-C Study Group
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved..
BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, the world has a large number of reported COVID-19 cases and deaths. Information on characteristics and mortality rate of pediatric intensive care unit (PICU) cases with COVID-19 remains limited. This study aims to identify the risk factors for mortality related to COVID-19 in children admitted to PICU.
METHODS: A retrospective multicenter cohort study was conducted between March 2020 and April 2021 at 44 PICUs in Turkey. Children who were 1 month-18-year of age with confirmed COVID-19 admitted to PICU were included in the study. Children with multisystem inflammatory syndrome and asymptomatic for COVID-19 were excluded.
RESULTS: Of 335 patients with COVID-19, the median age was 6.8 years (IQR: 1.2-14) and 180 (53.7 %) were male, 215 (64.2 %) had at least one comorbidity. Age and gender were not related to mortality. Among 335 patients, 166 (49.5%) received mechanical ventilation, 17 (5.1%) received renal replacement therapy and 44 (13.1 %) died. Children with medical complexity, congenital heart disease, immunosuppression and malignancy had significantly higher mortality. On multivariable logistic regression analysis, organ failure index [odds ratio (OR): 2.1, 95 confidence interval (CI): 1.55-2.85], and having congenital heart disease (OR: 2.65, 95 CI: 1.03-6.80), were associated with mortality.
CONCLUSIONS: This study presents detailed data on clinical characteristics and outcomes of patients with COVID-19 admitted to PICU in the first pandemic year in Turkey. Our study shows that having congenital heart disease is associated with mortality. In addition, the high organ failure score in follow-up predict mortality.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
The Pediatric infectious disease journal - 41(2022), 9 vom: 01. Sept., Seite 742-750 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Akcay, Nihal [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 11.08.2022 Date Revised 12.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1097/INF.0000000000003592 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342247573 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342247573 | ||
003 | DE-627 | ||
005 | 20231226013650.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/INF.0000000000003592 |2 doi | |
028 | 5 | 2 | |a pubmed24n1140.xml |
035 | |a (DE-627)NLM342247573 | ||
035 | |a (NLM)35703298 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Akcay, Nihal |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mortality Risk Factors Among Critically Ill Children With Acute COVID-19 in PICUs |b A Multicenter Study From Turkish Pediatric Critical COVID-19 and MIS-C Study Group |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.08.2022 | ||
500 | |a Date Revised 12.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. | ||
520 | |a BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, the world has a large number of reported COVID-19 cases and deaths. Information on characteristics and mortality rate of pediatric intensive care unit (PICU) cases with COVID-19 remains limited. This study aims to identify the risk factors for mortality related to COVID-19 in children admitted to PICU | ||
520 | |a METHODS: A retrospective multicenter cohort study was conducted between March 2020 and April 2021 at 44 PICUs in Turkey. Children who were 1 month-18-year of age with confirmed COVID-19 admitted to PICU were included in the study. Children with multisystem inflammatory syndrome and asymptomatic for COVID-19 were excluded | ||
520 | |a RESULTS: Of 335 patients with COVID-19, the median age was 6.8 years (IQR: 1.2-14) and 180 (53.7 %) were male, 215 (64.2 %) had at least one comorbidity. Age and gender were not related to mortality. Among 335 patients, 166 (49.5%) received mechanical ventilation, 17 (5.1%) received renal replacement therapy and 44 (13.1 %) died. Children with medical complexity, congenital heart disease, immunosuppression and malignancy had significantly higher mortality. On multivariable logistic regression analysis, organ failure index [odds ratio (OR): 2.1, 95 confidence interval (CI): 1.55-2.85], and having congenital heart disease (OR: 2.65, 95 CI: 1.03-6.80), were associated with mortality | ||
520 | |a CONCLUSIONS: This study presents detailed data on clinical characteristics and outcomes of patients with COVID-19 admitted to PICU in the first pandemic year in Turkey. Our study shows that having congenital heart disease is associated with mortality. In addition, the high organ failure score in follow-up predict mortality | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
700 | 1 | |a Kihtir, Hasan Serdar |e verfasserin |4 aut | |
700 | 1 | |a Durak, Cansu |e verfasserin |4 aut | |
700 | 1 | |a Kendirli, Tanil |e verfasserin |4 aut | |
700 | 1 | |a Havan, Merve |e verfasserin |4 aut | |
700 | 1 | |a Kockuzu, Esra |e verfasserin |4 aut | |
700 | 1 | |a Bozan, Gurkan |e verfasserin |4 aut | |
700 | 1 | |a Sevketoglu, Esra |e verfasserin |4 aut | |
700 | 0 | |a TuPCOM Study Group |e verfasserin |4 aut | |
700 | 1 | |a Varol, Fatih |e investigator |4 oth | |
700 | 1 | |a Uyar, Emel |e investigator |4 oth | |
700 | 1 | |a Özçifçi, Gökçen |e investigator |4 oth | |
700 | 1 | |a Şik, Güntülü |e investigator |4 oth | |
700 | 1 | |a Terzi, Kivanç |e investigator |4 oth | |
700 | 1 | |a Yesilbaş, Osman |e investigator |4 oth | |
700 | 1 | |a Yildizdaş, Dinçer |e investigator |4 oth | |
700 | 1 | |a Akyildiz, Başak |e investigator |4 oth | |
700 | 1 | |a Öztürk, Makbule Nilüfer Yalindağ |e investigator |4 oth | |
700 | 1 | |a Yazar, Abdullah |e investigator |4 oth | |
700 | 1 | |a Yener, Nazik |e investigator |4 oth | |
700 | 1 | |a Petmezci, Mey Talip |e investigator |4 oth | |
700 | 1 | |a Bayraktar, Süleyman |e investigator |4 oth | |
700 | 1 | |a Oto, Arzu |e investigator |4 oth | |
700 | 1 | |a Duyu, Muhterem |e investigator |4 oth | |
700 | 1 | |a Yükselmiş, Ufuk |e investigator |4 oth | |
700 | 1 | |a Kutlu, Nurettin Onur |e investigator |4 oth | |
700 | 1 | |a Altuğ, Ümüt |e investigator |4 oth | |
700 | 1 | |a Topal, Sevgi |e investigator |4 oth | |
700 | 1 | |a Öztürk, Zeynelabidin |e investigator |4 oth | |
700 | 1 | |a Akkuzu, Emine |e investigator |4 oth | |
700 | 1 | |a Besci, Tolga |e investigator |4 oth | |
700 | 1 | |a Özkaya, Pinar Yazici |e investigator |4 oth | |
700 | 1 | |a Durak, Fatih |e investigator |4 oth | |
700 | 1 | |a Aslan, Nagehan |e investigator |4 oth | |
700 | 1 | |a Sandal, Özlem Saraç |e investigator |4 oth | |
700 | 1 | |a Ödek, Çağlar |e investigator |4 oth | |
700 | 1 | |a Barlas, Ülkem Kocoğlu |e investigator |4 oth | |
700 | 1 | |a Çeleğen, Mehmet |e investigator |4 oth | |
700 | 1 | |a Özkale, Murat |e investigator |4 oth | |
700 | 1 | |a Kangin, Murat |e investigator |4 oth | |
700 | 1 | |a Atay, Gürkan |e investigator |4 oth | |
700 | 1 | |a Çoban, Yasemin |e investigator |4 oth | |
700 | 1 | |a Alaçakir, Nuri |e investigator |4 oth | |
700 | 1 | |a Kamit, Fulya |e investigator |4 oth | |
700 | 1 | |a Yaman, Ayhan |e investigator |4 oth | |
700 | 1 | |a Yetimakman, Ayşe Filiz |e investigator |4 oth | |
700 | 1 | |a Sofuoğlu, Ayşe İrem |e investigator |4 oth | |
700 | 1 | |a Aygün, Fatih |e investigator |4 oth | |
700 | 1 | |a Gurbanov, Anar |e investigator |4 oth | |
700 | 1 | |a Ersoy, Murat |e investigator |4 oth | |
700 | 1 | |a Bozdemir, Şefika Elmas |e investigator |4 oth | |
700 | 1 | |a Kiral, Eylem |e investigator |4 oth | |
700 | 1 | |a Şahin, Ebru |e investigator |4 oth | |
700 | 1 | |a Perk, Oktay |e investigator |4 oth | |
700 | 1 | |a Çitak, Agop |e investigator |4 oth | |
700 | 1 | |a Bayrakçi, Benan |e investigator |4 oth | |
700 | 1 | |a Gayretli Aydin, Zeynep Gökçe |e investigator |4 oth | |
700 | 1 | |a Ekinci, Faruk |e investigator |4 oth | |
700 | 1 | |a Çetin, Benhur Şirvan |e investigator |4 oth | |
700 | 1 | |a Girgin, Feyza İnceköy |e investigator |4 oth | |
700 | 1 | |a Akin, Fatih |e investigator |4 oth | |
700 | 1 | |a Albayrak, Hatice |e investigator |4 oth | |
700 | 1 | |a Boyraz, Merve |e investigator |4 oth | |
700 | 1 | |a Utku, Hatice Sinav |e investigator |4 oth | |
700 | 1 | |a Yazici, Mutlu Uysal |e investigator |4 oth | |
700 | 1 | |a Arslan, Gazi |e investigator |4 oth | |
700 | 1 | |a Ersayoğlu, İrem |e investigator |4 oth | |
700 | 1 | |a Birbilen, Ahmet Ziya |e investigator |4 oth | |
700 | 1 | |a Soydan, Ekin |e investigator |4 oth | |
700 | 1 | |a Bülbül, Beyhan |e investigator |4 oth | |
700 | 1 | |a Ongun, Ebru Atike |e investigator |4 oth | |
700 | 1 | |a Özkale, Yasemin |e investigator |4 oth | |
700 | 1 | |a Talay, Mehmet Nur |e investigator |4 oth | |
700 | 1 | |a Erdoğan, Seher |e investigator |4 oth | |
700 | 1 | |a Menentoğlu, Mehmet Emin |e investigator |4 oth | |
700 | 1 | |a Oğur, Mustafa |e investigator |4 oth | |
700 | 1 | |a Duman, Murat |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The Pediatric infectious disease journal |d 1991 |g 41(2022), 9 vom: 01. Sept., Seite 742-750 |w (DE-627)NLM012615706 |x 1532-0987 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2022 |g number:9 |g day:01 |g month:09 |g pages:742-750 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/INF.0000000000003592 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2022 |e 9 |b 01 |c 09 |h 742-750 |